How Pelosi’s impeachment inquiry into Trump could be a plus for one stock sector
September 24, 2019 at 18:27 PM EDT
As the move to impeach President Donald Trump moves forward, one analyst contends that the proceedings could essentially bring Congress to even more of a screeching halt, notably on a bill that would curb some drug prices from pharmaceutical companies.